Factor Xa Activated HC (AA 190-270), (Cleaved-Ile235) anticorps
L’anticorps anti-Factor Xa Activated HC Polyclonal Lapin est utilisé pour la détection de Factor Xa Activated HC dans des échantillons de Humain, Souris et Rat. Il a été validé pour ELISA et WB.
Aperçu rapide pour Factor Xa Activated HC (AA 190-270), (Cleaved-Ile235) anticorps (ABIN7220410)
Antigène
Factor Xa Activated HC
Reactivité
Humain, Souris, Rat
Hôte
Lapin
Clonalité
Polyclonal
Conjugué
Inconjugué
Application
ELISA, Western Blotting (WB)
Épitope
AA 190-270, Cleaved-Ile235
Fonction
Rabbit Anti-Cleaved-Factor Xa activated HC (I235) Polyclonal Antibody
Specificité
Cleaved-Factor Xa activated HC (I235) Polyclonal Antibody detects endogenous levels of fragment of activated Factor Xa activated HC protein resulting from cleavage adjacent to I235.
Purification
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Immunogène
Synthesized peptide derived from the Internal region of human Factor Xa activated HC at AA range: 190-270
Reactivité: Humain, Souris, Rat
ELISA, WB
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,ELISA 1:20000,Not yet tested in other applications.
Restrictions
For Research Use only
Format
Liquid
Concentration
1 mg/mL
Buffer
Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
-20 °C
Stockage commentaire
Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Date de péremption
12 months
Antigène
Factor Xa Activated HC
Sujet
F10, Coagulation factor X, Stuart factor, Stuart-Prower factorF10 encodes the vitamin K-dependent coagulation factor X of the blood coagulation cascade. This factor undergoes multiple processing steps before its preproprotein is converted to a mature two-chain form by the excision of the tripeptide RKR. Two chains of the factor are held together by 1 or more disulfide bonds, the light chain contains 2 EGF-like domains, while the heavy chain contains the catalytic domain which is structurally homologous to those of the other hemostatic serine proteases. The mature factor is activated by the cleavage of the activation peptide by factor IXa (in the intrisic pathway), or by factor VIIa (in the extrinsic pathway). The activated factor then converts prothrombin to thrombin in the presence of factor Va, Ca+2, and phospholipid during blood clotting. Mutations of this gene result in factor X deficiency, a hemorrhagic condition of variable severity. Alternative splicing results in multiple transcript variants encoding different isoforms that may undergo similar proteolytic processing to generate mature polypeptides.